ADIAL PHARMACEUTICALS
Adial Pharmaceuticals engages in the development of prescription medications for addiction and related disorders in the United States. The company's research pipeline includes AD04, a compound that completed the Phase IIb study for the treatment of alcohol use disorders; and AD01, which completed the Phase I clinical-stage for treating addictive behaviors.
ADIAL PHARMACEUTICALS
Industry:
Addiction Treatment Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
Charlottesville, Virginia, United States
Country:
United States
Website Url:
http://www.adialpharma.com
Total Employee:
11+
Status:
Active
Contact:
434-422-9800
Email Addresses:
[email protected]
Total Funding:
34.32 M USD
Technology used in webpage:
Amazon Facebook Sharer Amazon California Region
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
TowerView Health
TowerView Health develops an application for patients to manage medications.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Keystone Capital Partners
Keystone Capital Partners investment in Post-IPO Equity - Adial Pharmaceuticals
Richard Gilliam
Richard Gilliam investment in Post-IPO Equity - Adial Pharmaceuticals
Bespoke Growth Partners
Bespoke Growth Partners investment in Post-IPO Equity - Adial Pharmaceuticals
Keystone Capital Partners
Keystone Capital Partners investment in Post-IPO Equity - Adial Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2024-01-18 | Adial Pharmaceuticals appoints Tony Goodman as COO |
| 2022-08-22 | Adial Pharmaceuticals Names Cary Claiborne as Chief Executive Officer |
Official Site Inspections
http://www.adialpharma.com
- Host name: 172.67.178.165
- IP address: 172.67.178.165
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Adial Pharmaceuticals"
Adial Pharmaceuticals Inc. | ABOUT
Adial Pharmaceuticals was founded on November 23, 2010 in Charlottesville, Virginia to develop and commercialize medications for the treatment of addictions and related disorders.See details»
Adial Pharmaceuticals (NASDAQ: ADIL) - LinkedIn
Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company’s lead investigational new drug product, AD04, is a ...See details»
Adial Pharmaceuticals
Jun 17, 2025 Adial Pharmaceuticals was founded in 2007 by Founding Chairman and CEO, William Stilley, M.D. The Company focuses on researching, developing and commercializing …See details»
Adial Pharmaceuticals - Crunchbase Company Profile
Adial Pharmaceuticals develops prescription medications for addiction and related disorders.See details»
ADial Pharmaceuticals • UVA Licensing & Ventures Group
Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of a therapeutic agent for the treatment of alcohol use disorder “AUD” using our lead investigational new drug product, AD04.See details»
Company - Adial Pharmaceuticals Inc.
The Adial Vision To build the world’s leading pharmaceutical company focused on improving the quality of life of patients by preventing and treating addiction and other unmet medical needs.See details»
Adial Pharmaceuticals Inc. | MANAGEMENT
William B. Stilley has served as our Chief Executive Officer since co-founding the company in December 2010. Prior to joining Adial Pharmaceuticals, he was the Vice President, Business …See details»
Adial Pharmaceuticals Company Profile | Management and
Adial Pharmaceuticals Profile and History Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions.See details»
Adial Pharmaceuticals CEO and Key Executive Team - Craft.co
Adial Pharmaceuticals's Director is Tony Goodman. Other executives include Kevin Schuyler, Vice Chairman & Lead Independent Director; James W. Newman, Director and 5 others. See …See details»
Adial Pharmaceuticals Inc - Company Profile - GlobalData
Adial Pharmaceuticals Inc (Adial Pharma) is a clinical-stage biopharmaceutical company that develops therapeutic agents. The company's pipeline product include AD04, is for the …See details»
Adial Pharmaceuticals Inc. | BOARD OF DIRECTORS
He has guest lectured at the Darden School of Business in two courses on the management of life science companies, and serves on the Advisory Board of Virginia BIO, the statewide …See details»
Management Team Archives - Adial Pharmaceuticals Inc.
Cary Claiborne was named Chief Executive Officer in August 2022 after previously being appointed Chief Operating Officer in December 2021 and being named to the Board of …See details»
Adial Pharmaceuticals Reports Second Quarter 2025 Financial
1 day ago If you are interested in exploring partnership opportunities with Adial, we invite you to reach out to us ([email protected]) to discuss how our joint efforts can bring about …See details»
Contact - Adial Pharmaceuticals Inc.
Reach out to Adial Pharmaceuticals for media, investor, or business inquiries.See details»
Adial Corporate Presentartion - adialpharma.com
By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics, and healthcare, regulatory and scientific developments and …See details»
Adial Pharmaceuticals Reports Second Quarter 2025 Financial
10 hours ago GLEN ALLEN, Va., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company …See details»
Pipeline - Adial Pharmaceuticals Inc.
Discover Adial Pharmaceuticals’ development pipeline and its possible alcohol addiction treatment options.See details»
Adial Pharmaceuticals Inc. | About Adial
About Adial 16445 wp-singular,page-template-default,page,page-id-16445,wp-theme-bridge,bridge-core-2.5.8,ajax_fade,page_not_loaded,,qode-theme-ver-24.3,qode-theme …See details»
News / Events - Adial Pharmaceuticals Inc.
Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting Adial Pharmaceuticals Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement Adial Pharmaceuticals …See details»
Adial Pharmaceuticals Inc. | TECHNOLOGY
The Company’s lead compound AD04 (“AD04”) is a genetically targeted therapeutic agent for the treatment of Alcohol Use Disorder (AUD) and is currently being investigated in a Phase 3 …See details»